Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

Related Articles by Review for PubMed (Select 9301661)

1.

Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.

Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, Nichols DE.

J Med Chem. 1997 Sep 12;40(19):2997-3008.

PMID:
9301661
2.

Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).

Backstrom JR, Chang MS, Chu H, Niswender CM, Sanders-Bush E.

Neuropsychopharmacology. 1999 Aug;21(2 Suppl):77S-81S. Review.

3.

Stereoselective pharmacological effects of lysergic acid amides possessing chirality in the amide substituent.

Nichols DE, Monte A, Huang X, Marona-Lewicka D.

Behav Brain Res. 1996;73(1-2):117-9. Review.

PMID:
8788487
4.

Serotonin and hallucinogens.

Aghajanian GK, Marek GJ.

Neuropsychopharmacology. 1999 Aug;21(2 Suppl):16S-23S. Review.

5.

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

Halberstadt AL, Geyer MA.

Neuropharmacology. 2011 Sep;61(3):364-81. doi: 10.1016/j.neuropharm.2011.01.017. Epub 2011 Jan 20. Review.

6.

Role of the serotonin 5-HT(2A) receptor in learning.

Harvey JA.

Learn Mem. 2003 Sep-Oct;10(5):355-62. Review.

7.

Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents.

Glennon RA, Rosecrans JA, Young R.

Med Res Rev. 1983 Jul-Sep;3(3):289-340. Review. No abstract available.

PMID:
6350763
8.

Fluorine in psychedelic phenethylamines.

Trachsel D.

Drug Test Anal. 2012 Jul-Aug;4(7-8):577-90. doi: 10.1002/dta.413. Epub 2012 Feb 28. Review.

PMID:
22374819
9.

Indolealkylamine and phenalkylamine hallucinogens: a brief overview.

Glennon RA, Rosecrans JA.

Neurosci Biobehav Rev. 1982 Winter;6(4):489-97. Review.

PMID:
6757811
10.

The pharmacology of hallucinogens.

Brawley P, Duffield JC.

Pharmacol Rev. 1972 Mar;24(1):31-66. Review. No abstract available.

PMID:
4626282
11.

The mechanism of action of hallucinogenic drugs on a possible serotonin receptor in the brain.

Smythies JR, Benington F, Morin RD.

Int Rev Neurobiol. 1970;12:207-33. Review. No abstract available.

PMID:
4918144
12.

Neurological aspects of hallucinogenic drugs.

Logan WJ.

Adv Neurol. 1975;13:47-78. Review. No abstract available.

PMID:
814800
13.

Hallucinogens, serotonin and obsessive-compulsive disorder.

Delgado PL, Moreno FA.

J Psychoactive Drugs. 1998 Oct-Dec;30(4):359-66. Review.

PMID:
9924841
14.

Hallucinogens as discriminative stimuli.

Winter JC.

Fed Proc. 1974 Jul;33(7):1825-32. Review. No abstract available.

PMID:
4209212
15.

Modulation of serotonin2A/2C receptors and these receptor-linked phosphoinositide system by ethanol.

Pandey SC, Pandey GN.

Behav Brain Res. 1996;73(1-2):235-8. Review.

PMID:
8788509
16.

The behavioral pharmacology of hallucinogens.

Fantegrossi WE, Murnane KS, Reissig CJ.

Biochem Pharmacol. 2008 Jan 1;75(1):17-33. Epub 2007 Jul 20. Review.

17.

Psychotomimetic drugs: biochemistry and pharmacology.

Brimblecombe RW.

Adv Drug Res. 1973;7:165-206. Review. No abstract available.

PMID:
4613150
18.

Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.

Westkaemper RB, Glennon RA.

NIDA Res Monogr. 1994;146:263-83. Review. No abstract available.

PMID:
8742803
19.

Interactions of hallucinogens at the clinical level.

Wyatt RJ, Cannon EH, Stoff DM, Gillin JC.

Ann N Y Acad Sci. 1976;281:456-86. Review. No abstract available.

PMID:
828469
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk